Business Wire

NOSTO

Share
Nosto lands $17 Million to own Ecommerce Personalization

Nosto, the industry leading personalization software solution for online retailers, has secured $17 million in funding from the European Investment Bank, which will be used to accelerate Nosto’s continuous product innovation and research program and to fuel Nosto’s expansion within the US and EMEA regions, as well as entry into new markets. This will enable the development of more innovative features using Nosto’s cutting-edge patented technology to help retailers grow their businesses with strong local support by skilled professionals.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170713005374/en/

“We have developed a breakthrough SaaS platform that makes it easy for retailers to deliver personalized shopping experiences to every individual across all touchpoints. This is an exciting stage in our company’s growth and we’ll continue to focus our capital and energy on building a great product to empower retailers to succeed. This funding allows us to further innovate and continue our mission of connecting people with products across their entire shopping journey,” says Juha Valvanne, one of the founders of Nosto.

With the mission of making it easy for retailers to deliver their customers personalized shopping experiences, at every touch point, across every device, Nosto offers its multi-channel online personalization solution for online retailers worldwide, aiming to create a fully personalized customer journey through the use of real-time, targeted product recommendations.

By analyzing hundreds of thousands of data points in online stores to build a deep understanding of every customer in real-time, Nosto’s patented technology empowers retailers to deliver the right product ads to the right users at the right time through personalized product recommendations on websites, mobile apps, emails and social ads.

Nosto has forged strong partnerships with top level ecommerce platforms such as Magento and Shopify Plus, ensuring high quality service for its customers. As of April 2017 Nosto also became an official Facebook Marketing Partner, joining an exclusive group of companies known for their excellence on the platform. The customer base includes leading brands such as Twinings, Jack Daniels, Everlast and Volcom.

"The funding will help us grow our operations and introduce our cutting-edge patented technology to new markets. We will use the funding to keep attracting even more talents to our international team as well as investing in our personnel and product development. All of this will fuel our worldwide growth and expansion even further. Our aim is to be the global leader in ecommerce personalization," says Matti Rönkkö, CEO of Nosto.

The loan is one of the largest that has been provided to a startup company by the European Fund for Strategic Investments (EFSI), a joint initiative of the European Investment Bank and European Commission.

European Commission Vice-President Jyrki Katainen, responsible for Jobs, Growth, Investment and Competitiveness, said: “Global expansion and developing innovative products demands investment. Investing in research is a critical factor in ensuring that European companies, such as Nosto, maintain their status as innovation leaders in e-commerce when competing in the global marketplace. I am delighted that the European Fund for Strategic Investments is playing an important role in facilitating such investments.”

In addition to EIB, the company is backed by investors such as Wellington Partners and Open Ocean Capital. The resources provided will aid in Nosto’s growth plans, which include hiring engineers to the Nosto headquarter located in Helsinki and increasing its sales and marketing teams in New York, London, Stockholm and Berlin. Additionally, Nosto will open its Los Angeles office in the fall to strengthen its support in the US market and will be recruiting skilled professionals.

About Nosto

Nosto enables online retailers to deliver their customers personalized shopping experiences at every touch point, across every device. A powerful personalization solution designed for ease of use, Nosto empowers retailers to build, launch and optimize 1:1 multi-channel marketing campaigns without the need for dedicated IT resources. Leading retail brands in over 100 countries use Nosto to grow their business and delight their customers. Nosto supports its retailers from its offices in Helsinki, Berlin, Stockholm, London and New York.

Contact:

Nosto
Lena Grosse
Email: lena.grosse@nosto.com
Tel.: +49 176 61 98 68 29

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release

Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release

IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye